These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 21644042)

  • 21. Association of the TNF-α G-308A polymorphism with TNF-inhibitor response in sarcoidosis.
    Wijnen PA; Cremers JP; Nelemans PJ; Erckens RJ; Hoitsma E; Jansen TL; Bekers O; Drent M
    Eur Respir J; 2014 Jun; 43(6):1730-9. PubMed ID: 24558177
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and safety of tumor necrosis factor antagonists in refractory sarcoidosis: A multicenter study of 132 patients.
    Jamilloux Y; Cohen-Aubart F; Chapelon-Abric C; Maucort-Boulch D; Marquet A; Pérard L; Bouillet L; Deroux A; Abad S; Bielefeld P; Bouvry D; André M; Noel N; Bienvenu B; Proux A; Vukusic S; Bodaghi B; Sarrot-Reynauld F; Iwaz J; Amoura Z; Broussolle C; Cacoub P; Saadoun D; Valeyre D; Sève P;
    Semin Arthritis Rheum; 2017 Oct; 47(2):288-294. PubMed ID: 28392046
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term efficacy of adalimumab in paediatric Crohn's disease patients naïve to other anti-TNF therapies.
    Martín-de-Carpi J; Pociello N; Varea V
    J Crohns Colitis; 2010 Nov; 4(5):594-8. PubMed ID: 21122566
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anti-TNF therapeutics for the treatment of sarcoidosis.
    Crommelin HA; Vorselaars AD; van Moorsel CH; Korenromp IH; Deneer VH; Grutters JC
    Immunotherapy; 2014; 6(10):1127-43. PubMed ID: 25428650
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Practical eminence and experience-based recommendations for use of TNF-α inhibitors in sarcoidosis.
    Drent M; Cremers JP; Jansen TL; Baughman RP
    Sarcoidosis Vasc Diffuse Lung Dis; 2014 Jul; 31(2):91-107. PubMed ID: 25078637
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adalimumab as steroid-sparing treatment of inflammatory-stage thyroid eye disease.
    Ayabe R; Rootman DB; Hwang CJ; Ben-Artzi A; Goldberg R
    Ophthalmic Plast Reconstr Surg; 2014; 30(5):415-9. PubMed ID: 24978425
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Head and neck sarcoidosis, from wait and see to tumor necrosis factor alpha therapy: a pilot study.
    Knopf A; Lahmer T; Chaker A; Stark T; Hofauer B; Pickhard A; Thürmel K; Bas M
    Head Neck; 2013 May; 35(5):715-9. PubMed ID: 22730039
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Concomitant therapy with methotrexate and anti-TNF-α in pediatric patients with refractory crohn's colitis: a case series.
    Absah I; Faubion WA
    Inflamm Bowel Dis; 2012 Aug; 18(8):1488-92. PubMed ID: 21882301
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Durable medication-free remission of sarcoidosis following discontinuation of anti-tumor necrosis factor-α therapy.
    Yee AMF
    Respir Med; 2023 Jan; 206():107055. PubMed ID: 36459954
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Management of ocular sarcoidosis.
    Baughman RP; Lower EE; Ingledue R; Kaufman AH
    Sarcoidosis Vasc Diffuse Lung Dis; 2012 Mar; 29(1):26-33. PubMed ID: 23311120
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy and safety of adalimumab in patients with psoriasis previously treated with anti-tumour necrosis factor agents: subanalysis of BELIEVE.
    Ortonne JP; Chimenti S; Reich K; Gniadecki R; Sprøgel P; Unnebrink K; Kupper H; Goldblum O; Thaçi D
    J Eur Acad Dermatol Venereol; 2011 Sep; 25(9):1012-20. PubMed ID: 21214631
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Steroid-resistant sarcoidosis: is antagonism of TNF-alpha the answer?
    Denys BG; Bogaerts Y; Coenegrachts KL; De Vriese AS
    Clin Sci (Lond); 2007 Mar; 112(5):281-9. PubMed ID: 17261090
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adalimumab Induced Subcutaneous Nodular Sarcoidosis; A Rare Side Effect of Tumor Necrosis Factor-α Inhibitor.
    Au S; Mirsaeidi M; Aronson IK; Sweiss NJ
    Sarcoidosis Vasc Diffuse Lung Dis; 2014 Oct; 31(3):249-51. PubMed ID: 25363227
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Misdiagnosed childhood sarcoidosis as non-Langerhans' cell histiocytosis treated with tumor necrosis factors-α antagonists].
    Petiti Martin G; Castellanos González M; Sanz Bueno J; Burgués Calderón M; Villar Buil M; Vanaclocha F; Peralto JL
    An Pediatr (Barc); 2012 Oct; 77(4):267-71. PubMed ID: 22608978
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mucosal healing at 3 months predicts long-term endoscopic remission in anti-TNF-treated luminal Crohn's disease.
    af Björkesten CG; Nieminen U; Sipponen T; Turunen U; Arkkila P; Färkkilä M
    Scand J Gastroenterol; 2013 May; 48(5):543-51. PubMed ID: 23477356
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Efficacy and safety of Adalimumab in Crohn's disease].
    Serghini M; Haddad W; Jeddi H; Karoui S; Ben Mustapha N; Kallel L; Fekih M; Matri S; Boubaker J; Filali A
    Tunis Med; 2012 Feb; 90(2):101-7. PubMed ID: 22407620
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumor necrosis factor-α inhibitor use for treatment of refractory cardiac sarcoidosis in a patient with left ventricular assist device: Adalimumab use in refractory sarcoidosis in a patient with left ventricular assist device.
    Krishnan M; Cupps TR; Sheikh FH
    J Heart Lung Transplant; 2020 Dec; 39(12):1504-1505. PubMed ID: 32830024
    [No Abstract]   [Full Text] [Related]  

  • 38. Tumor necrosis factor inhibitors in patients with Takayasu arteritis: experience from a referral center with long-term followup.
    Schmidt J; Kermani TA; Bacani AK; Crowson CS; Matteson EL; Warrington KJ
    Arthritis Care Res (Hoboken); 2012 Jul; 64(7):1079-83. PubMed ID: 22328491
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adalimumab produces clinical remission and reduces extraintestinal manifestations in Crohn's disease: results from CARE.
    Löfberg R; Louis EV; Reinisch W; Robinson AM; Kron M; Camez A; Pollack PF
    Inflamm Bowel Dis; 2012 Jan; 18(1):1-9. PubMed ID: 21351211
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Refractory multisystem sarcoidosis responding to infliximab therapy.
    Croft AP; Situnayake D; Khair O; Giovanni G; Carruthers D; Sivaguru A; Gordon C
    Clin Rheumatol; 2012 Jun; 31(6):1013-8. PubMed ID: 22249374
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.